Discontinuation report VUMON
Report ID | 1647 |
Drug Identification Number | 00588989 |
Brand name | VUMON |
Common or Proper name | Teniposide |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TENIPOSIDE |
Strength(s) | 10MG |
Dosage form(s) | Liquid |
Route of administration | IM or SC |
Packaging size | 10amp x 5 ml |
ATC code | L01CB |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-05-31 |
Remaining supply date | 2018-05-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-06-01 | English | Compare |
v5 | 2017-04-03 | French | Compare |
v4 | 2017-04-03 | English | Compare |
v3 | 2017-04-03 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 6 of 6